Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ March 26, 2023 ] Quality Control Lead, Global Quality Control Microbiology – Kite Pharma – Santa Monica, CA Los Angeles Biotech Jobs
  • [ March 26, 2023 ] Aadi Bioscience Presents Clinical Data from PRECISION 1 and AMPECT Trials at the Society of Gynecological Oncology (SGO) Annual Meeting on Women’s Cancer Los Angeles Biotech News
  • [ March 26, 2023 ] Research Associate – Aptitude Medical – Santa Barbara, CA Los Angeles Biotech Jobs
  • [ March 26, 2023 ] Lab Manager (Research Program Administrator) – CEDARS-SINAI – Los Angeles, CA Los Angeles Biotech Jobs
  • [ March 26, 2023 ] Sr Account Director, Business Development – (GMP Labs) – West Coast Region – Thermo Fisher Scientific – Los Angeles, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsVYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (minocycline) topical foam, 4%

VYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (minocycline) topical foam, 4%

December 15, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on VYNE Therapeutics Announces New U.S. Patent Expiring in 2037 for AMZEEQ® (minocycline) topical foam, 4%
New Granted Patent Listed in FDA’s Orange Book for AMZEEQ
New Granted Patent Listed in FDA’s Orange Book for AMZEEQ

Click to view original post

Previous

Famous NTS Test Lab in Los Angles Adds More Thermal Vacuum Chambers to Expand Role in Race to Space

Next

Sensei Ag Appoints Leading Agricultural Expert Jijun Zou as Chief Scientific Officer

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered